Wolfe Research Upgrades Janux Therapeutics to Outperform, Announces $23 Price Target

Benzinga · 3d ago
Wolfe Research analyst Kalpit Patel upgrades Janux Therapeutics (NASDAQ:JANX) from Peer Perform to Outperform and announces $23 price target.